Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth
JAMA · 2024
DOI: 10.1001/jama.2024.14243 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA, 2024. Verfasst von Rita Rubin. Beteiligte Einrichtung: Lead Senior Staff Writer, Medical News & Perspectives, JAMA. Hauptthemen laut MEDLINE: Electronic Nicotine Delivery Systems, Flavoring Agents, Menthol, United States Food and Drug Administration. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
This Medical News story examines the controversy surrounding the FDA’s first authorization of flavored e-cigarettes, in this case menthol.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lead Senior Staff Writer, Medical News & Perspectives, JAMA.
Zitieren
APA
Rubin, R. (2024). Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth. JAMA. https://doi.org/10.1001/jama.2024.14243
Vancouver
Rubin R. Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth. JAMA. 2024. doi:10.1001/jama.2024.14243
BibTeX
@article{Rubin2024,
author = {Rubin, Rita},
title = {Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.14243}
}
EUVIMED